US based advanced API manufacturing. Base period funding for US based advanced manufacturing of covid-19 essential medicines and future threats.

Active Definitive Contract Awarded Last action

Contract number
75A50120C00092
Awardee
Awarding agency
Obligated
$696,665,954

Award facts

Opportunity
Contract value 72% obligated
  • $708,849,575.90 Current, with exercised options
  • $969,754,681.90 Potential, with all options
Completion date 65% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Richmond, VA 23219, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Definitize Change Order P00039 · The purpose of this modification is to extend the clin POP and planned definitization date of the change order issued on P00020 from september 29, 2026 to… $0
Change Order P00038 $0
Change Order P00037 · The purpose of this modification is to extend the planned definitization date of the change order issued on P00020 from august 25, 2026 to september 29, 2026. $0
Definitize Change Order P00036 · The purpose of this modification is to the extend the planned definitization date of the change order issued on P00022 from july 3, 2026 to september 3, 2026. $0
Definitize Change Order P00034 · The purpose of this modification is to change the planned definitization date of the change order issued on P00020 from june 25, 2026 to august 25, 2026 $0
Supplemental Agreement for work within scope P00033 · The purpose of this modification is to extend the POP for clins 8, 9, and 11 at no additional cost the government. $0
Definitize Change Order P00032 $0
Definitize Change Order P00031 $0
Definitize Change Order P00030 · The purpose of this action is to update the planned definitization date in P0022 from march 3, 2026 to may 3, 2026 $0
Supplemental Agreement for work within scope P00028 · The purpose of this action is to extend clin 0008 at no additional cost to the government $0
Change Order P00026 $26,374,409
Exercise an Option P00027 · The purpose of this action is to fund the remaining apis for the strategic reserve $53,900,000
Other Administrative Action P00025 · The purpose of modification P00020 is to exercise option clin 0010 and incorporate changes to the description of services for domestic producibility of… $0
Other Administrative Action P00024 · COR change $0
Supplemental Agreement for work within scope P00023 · Add clause far 52.232-16 progress payments (NOV 2021) alternate I (MAR 2000) $0
Change Order P00022 · Revise the scope of effort $25,000,000
Other Administrative Action P00021 · Update POC information $0
Change Order P00020 · The purpose of modification P00020 is to exercise option clin 0010 and incorporate changes to the description of services for domestic producibility of… $8,366,747
Supplemental Agreement for work within scope P00019 · The purpose of modification P00019 is to extend the clins 0003, 0005, 0007, 0008 at no additional cost to the government. $0
Other Administrative Action P00018 · The purpose of this MOD is to update the CO from roger hernandez to kimberly golden $0
Supplemental Agreement for work within scope P00017 · The purpose of this modification is to extend the base period (clin 0003 and clin 0005) at no additional cost to the government, update language in #4 and add… $0
Supplemental Agreement for work within scope P00016 · The purpose of this modification is to issue an extension. $0
Supplemental Agreement for work within scope P00015 · Clin 0005 shall be increased from $334,423,625.23 by obligating $7,095,891.76 to a clin value of $341,519,516.99. $7,095,892
Supplemental Agreement for work within scope P00014 · Clin 0024 shall be increased from $0 by obligating $3,892,431.86 to a clin value of $3,892,431.86. $3,892,432
Exercise an Option P00013 · The purpose of this modification is to exercise option period 2 for clin 0009 and clin 0010 at full value. $52,271,774
Supplemental Agreement for work within scope P00012 · The purpose of this modification is to issue an extension to the base period and option period 1, incremental funding and adding cost overrun item of G & a on… $9,918,714
Supplemental Agreement for work within scope P00011 · Add $7,730,713.39 to the total contract value: $4,033,088.15 will be added to clin 0003 (U.S.- based production of active pharmaceutical ingredients (API) for… $7,730,713
Exercise an Option P00010 · 1. Change the period of performance for option period 1 at clin 0007 from 05/18/2024 through 05/17/2025 to 07/03/2024 through 07/02/2025. 2. Exercise clin… $10,209,870
Supplemental Agreement for work within scope P00009 · 1. Change the contractor address. As a result of this modification, block 8 of the SF30 reflects the updated address of 424 hull street, suite 400, richmond, VA… $0
Supplemental Agreement for work within scope P00008 · The purpose of modification P00008 is to: 1. Extend the base period of performance at clins 0001, 0003, 0004, and 0005, at no additional cost to the government;… $50,649,403
Other Administrative Action P00007 · The purpose of modification P00007 is to accept the transfer of contract administration from aspr/barda/PCI to aspr/ibmsc, and to make administrative changes to… $0
Other Administrative Action P00006 · The purpose of this modification is to transfer the contract from aspr/barda/PCI to aspr/ibmsc. $0
Supplemental Agreement for work within scope P00005 · The purpose of this modification is to revise the contract statement of objectives (SOO) and table C.1 of section C.3 statement of objectives. $0
Other Administrative Action P00004 · Incorporate hhsar clause 352.232-71, electronic submission of payment requests into section I of the contract and to also either add or update invoice… $0
Other Administrative Action P00003 $0
Funding Only Action P00002 $87,000,000
Other Administrative Action P00001 $0
Original award $354,256,000
Show all 38

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services awarded a $969.8 million definitive contract to Phlow Corp. for advanced API manufacturing and production of COVID-19 essential medicines on May 18, 2020. The contract carries a cost-plus-fixed-fee pricing structure with a ceiling value of $969.8 million and an ultimate completion date of May 17, 2030.

Work is performed in Richmond, Virginia. The originating Broad Agency Announcement from the Biomedical Advanced Research and Development Authority (BARDA) sought advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, with evaluation criteria including technical merit and relevance to BARDA's mission. A modification issued on P00020 extended the CLIN period-of-performance and planned definitization date from September 29, 2026 to November 29, 2026, reflecting base-period funding for U.S.-based advanced manufacturing of COVID-19 essential medicines and future pandemic threats.

Quick answers

Who was awarded contract 75A50120C00092?

75A50120C00092 was awarded to Phlow Corp. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 18, 2020.

How much is contract 75A50120C00092 worth?

The government has obligated $696,665,954 on 75A50120C00092. Its current value, with exercised options, is $708,849,576. Its potential value, with all options, is $969,754,682.

Was contract 75A50120C00092 competed?

The extent of competition for 75A50120C00092 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login